Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of GSK HRV Vaccine (Rotarix) in Healthy Infants
NCT00385320Phase 2Completed
- Sponsor
- GSK
- Start
- May 2001
- Primary completion
- Apr 2003
- Modality
- Live Attenuated Vaccines
01
Overview
Phase 2, randomised, double-blind trial of human rotavirus vaccine, live attenuated in rotavirus gastroenteritis (4 arms), sponsored by GSK. Primary endpoint: Occurrence of Rotavirus Gastroenteritis. Started May 2001; status: completed.
02
Drugs
human rotavirus vaccine, live attenuated
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT00385320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00385320.